$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Entomopathogenic nematodes (EPNs) are insect-killing parasites that form species-specific mutualistic partnerships with their bacterial symbionts1. EPNs consist of two families: Steinermatidae and Heterorhabditidae, which associate with Gram-negative bacteria of Photorhabdus and Xenorhabdus spp, respectively2,3. During the free-living infective juvenile stage (IJ) of Steinernema nematodes, Xenorhabdus bacteria are housed within an intestinal pocket of the nematode known as the receptacle, and upon penetration of the insect host into the hemocoel, the bacteria are released, after which they multiply, and kill the insect by septicaemia3,4. In this mutualistic relationship, the bacteria produce antimicrobial and insecticidal compounds, which protect against the host immune response and provide nutritional support to the nematode5. In return, the bacteria benefit from the protection provided by the nematode host against environmental microbes and are facilitated in their dispersal to new insect prey6,7.
Over the past few decades, the Steinernema-Xenorhabdus partnership has been established as a powerful experimental system to study various aspects of parasitic and mutualistic interactions, such as insect host-seeking behaviors3, bacterial colonization in the nematode host8, and adaptive behaviors of symbiotic bacteria that facilitate their transitions between nematodes and insect host animals9. EPNs are also important species in soil sustainability and are used as organic pest control agents to promote agricultural productivity10,11.
Despite the rapid development of genetic tools in the symbiotic bacteria Xenorhabdus and Photorhabdus12, consistent genetic tools in EPNs have been scarce. Gonadal microinjection has been successfully established in both Heterorhabditis and Steinernema nematodes13,14. Previously, gonadal microinjection in Heterorhabditis bacteriophora has been used to consistently deliver double-stranded RNA for gene knockdown among the first generation of progeny13,15. Recently, CRISPR-Cas9 genome editing in Steinernema has been developed, delivered via gonadal microinjection, and resulted in precise, stable, and heritable mutations14.
One Steinernema spp, S. hermaphroditum, has been demonstrated to be highly tractable and has great potential as an emerging genetic model organism4,14. Originally isolated from the soil in Indonesia16 and re-isolated in India17, S. hermaphroditum is consistently hermaphroditic, with a small number of males in each generation, two features that facilitate the adaptation of genetic tools from the classical model nematode C. elegans4. In addition, the genome of S. hermaphroditum has been sequenced and assembled into chromosomes, simplifying the task of identifying potential Cas9 target sites and designing primers18.
During microinjection of EPN, an injection mix containing appropriate reagents, such as dsRNAs, Cas9 protein, or guide RNAs, is delivered to the syncytial nematode gonad via a needle pulled from a quartz capillary. The appropriate volume and pressure of injection result in a visible 'flow' of liquid throughout the gonadal arm. Since these nematodes have a pair of syncytial gonads composed of germline nuclei that share the same cytosol19, this microinjection approach allows multiple germ cells to be accessible for editing, before cytokinesis occurs, separating the germline nuclei into developing oocytes20. Although gonadal microinjection serves as a consistent technique for genetic modulation in several species of non-model nematodes14,21,22,23,24,25, it is crucial to adapt the injection techniques to the appropriate gonadal structures, life stage, and physiological condition of each nematode species to ensure success and high efficiency in delivery. Recovery techniques post-injection and maintenance of mutant lines are both important to ensure this technique is cost-efficient.
This study demonstrates a CRISPR-Cas9 genome editing protocol in Steinernema hermaphroditum. The gonadal microinjection is described in the young adult, a stage that is resilient to high-pressure microinjection and is receptive to gene editing14. In addition, detailed methods describing the maintenance of heritable and stable mutant lines are provided, both via cryopreservation and propagation through insects.